Community-acquired pneumonia: A 7-years descriptive study. Usefulness of the IDSA/ATS 2007 in the assessment of ICU admission;Neumonía comunitaria grave. Estudio descriptivo de 7 años y utilidad de los criterios de la Infectious Diseases Society of America y la American Thoracic Society 2007 en la identificación de los pacientes que requieren ingreso en una unidad de cuidados intensivos

Medicina Intensiva

Volumn 34, Issue 4, 2010, Pages 237-245

  Sabatier, C ^a   Peredo, R ^a   Villagra A ^a   Bacelar, N ^a   Mariscal, D ^b   Ferrer, R ^a   Gallego, M ^a   Valles J ^a  

^a HOSPITAL DE SABADELL   (Spain)

^b UDIAT   (Spain)

Author keywords

Community acquired pneumonia; Intensive care unit; Prognostic factors

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; OUTCOME ASSESSMENT; PATIENT CODING; PRACTICE GUIDELINE; PROGNOSIS; SEPTIC SHOCK; STREPTOCOCCUS PNEUMONIAE;

EID: 77952888842     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2009.11.008     Document Type: Article

References (34)

1. Monge V., San-Martín V.M., González A. The burden of community-acquired pneumonia in Spain. Eur J Public Health 2001, 11:362-364.
2. Woodhead M., Welch C., Harrison D., Bellingan G., Ayres J.G.L. Community-acquired pneumonia on the intensive care unit: Secondary analysis of 17,869 cases in the ICNARC Case Mix Programme Database. Critical Care 2006, 10:S1.
3. Leroy O., Devos P., Guery B. Simplified rule for prognosis of patients with severe community-acquired pneumonia in ICUs. Chest 1999, 116:157-165.
4. Leroy O., Santre C., Beuscart C., Genges H., Guery B., Jacquier J.M., et al. A five year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995, 21:24-31.
5. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
6. Lim W.S., Van der Eerden M.M., Laing R. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 2003, 58:377-382.
7. Niederman M.S., Mandell L.A., Anzueto A., Bas J.B., Broughton W.A., Campbell G.D., et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001, 163:1730-1754.
8. Ewig S., de Roux A., Bauer T.T., García E., Mensa J., Niederman M., et al. Validation of predictive rules and indices of severity for community-acquired pneumonia. Thorax 2004, 59:421-427.
9. Alfageme I., Aspa J., Bello S., Blanquer J., Blanquer R., Borderías L., et al. Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol 2005, 41:272-289. Grupo de Estudio de la Neumonía Adquirida en la Comunidad. Área de Tuberculosis e Infecciones Respiratorias (TIR)-SEPAR.
10. Mandell L.A., Richard G., Anzueto A., Barlett J.G., Campbell G.D., Dean N.C., et al. Whitney IDSA/ATS Guidelines for CAP in Adults. CID 2007, 44:S27.
11. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995, 152:S78-S121. American Thoracic Society.
12. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. SCCM/ESICM/ACCP/ATS/SIS. Crit Care Med 2003, 31:1250-1256.
13. File T.M. Community-acquired pneumonia. Lancet 2003, 362:1991-2001.
14. Bodí M., Rodríguez A., Solé-Violán J., Gilavert M.C., Granacho J., Blanquer J., et al. Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: Impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 2005, 41:1709-1716.
15. Marrie T.J., Shariatzadeh M.R. Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore) 2007, 86:103-111.
16. Jong G.M., Hsiue T.R., Chen C.R., Chang H.Y., Chen C.W. Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics. Chest 1995, 107:214-217.
17. De Roux A., Cavalcanti M., Marcos M.A., García E., Ewig S., Mensa J., et al. Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia. Chest 2006, 129:1219-1225.
18. Ewig S., Ruiz M., Mensa J., Marcos M.A., Martínez J.A., Arancibia F., et al. Severe community-acquired pneumonia: assessment of severity criteria. Am J Respir Crit Care Med 1998, 158:1102-1108.
19. Yoshimoto A., Nakamura H., Fujimura N., Nakao S. Severe community-acquired pneumonia in an intensive care unit: Risk factors for mortality. Intern Med 2005, 44:710-716.
20. Wilson P.A., Ferguson J. Severe community-acquired pneumonia: An Australian perspective. Intern Med J 2005, 35:699-705.
21. Laterre P.F., Garber G., Levy H., Wunderink R., Kinasewitz G.T., Sollet J.P., et al. Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study. Crit Care Med 2005, 33:952-961. PROWESS Clinical Evaluation Committee.
22. Shorr A.F., Bodi M., Rodríguez A., Sole-Violan J., Garnacho-Motero J., Rello J. Impact of antibiotic guideline compliance on duration of mechanical ventilation in critically ill patients with community-acquired pneumonia. Chest 2006, 130:93-100. CAPUCI Study Investigators.
23. Rello J., Rodríguez A., Torres A., Roig J., Sole-Violan J., Garnacho-Montero J., et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 2006, 28:262-263.
24. File T.M., Garau J., Blasi F., Chidiac C., Klugman K., Lode H., et al. Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia. Chest 2004, 125:1888-1901.
25. Battleman D.S., Callahan M., Thaler H.T. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of stay of patients with communitty-acquired pneumonia: Link between quality of care and resource utilization. Arch Intern Med 2002, 162:682-688.
26. Houck P.M., Bratzler D.W., Nsa W., Ma A., Barlett J.G. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004, 164:637-644.
27. Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, et al. Effectiveness of treatments for severe sepsis: A prospective multicenter observational study. Am J Respir Crit Care Med. 2009;180:861-6.
28. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
29. Rello J., Rodríguez R., Jubert P., Álvarez B. Severe community-acquired pneumonia in the elderly: Epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia. Clin Infect Dis 1996, 23:723-728.
30. Rello J., Bodi M., Marical D., Navarro M., Díaz E., Gallego M., et al. Microbiological testing and outcome of patients with severe community-acquired pneumonia. Chest 2003, 124:1179-1180.
31. Almirall J., Mesalles E., Klamburg J., Parra O., Agudo A. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest 1995, 107:511-516.
32. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with Q18 hospital- acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Resp Crit Care Med. 2005;171:388-416.
33. Liapikou A., Ferrer M., Polverino E., Balasso V., Esperatti M., Piñer R., et al. Severe community-acquired pneumonia: Validation of the infectious disease society of America/American Thoracic Society Guidelines to Predict an Intensive Care Unit Admission. Clin Infect Dis 2009, 48:377-385.
34. Martín M.C., Cabré L., Ruiz J., Blanch L., Blanco J., Castillo F., et al. Indicadores de calidad en el paciente crítico. Med Intensiva 2008, 32:23-32. Grupos de trabajo de la Sociedad Española de Medicina Intensiva Crítica y Unidades Coronarias (SEMICYUC), Sociedad Española de Enfermería Intensiva y Unidades Coronarias (SEEIUC) and Fundación AVEDIS Donabedian (FAD).